HealthFlex
×
  • Home
  • For Patients
    • What is an ERN?
    • Understand your Diagnosis
    • News for Patients
    • Meetings & Events
    • Support Groups
      • Find a Health Care Professional
      • Contact
    • Cross-border Healthcare
  • Our Network
  • ERN Expertise
    • Rare Diseases Subnetworks
    • Transversal Activities
    • Work Packages
    • Patient Board
  • Media
    • Informative Materials
  • What's New
    • News
    • News for Patients
    • Meetings & Conferences
    • Newsletter
  • ERNs
  • Links
  • Contact
  • Privacy Policy

Phenylketonuria Round Table at the EU Parliament

Phenylketonuria Round Table at the EU Parliament
NewsNews for Patients

Prof Maurizio Scarpa (MetabERN Coordinator), Francjan van Spronsen (MetabERN Representative from Rijksuniversiteit Groningen (NL)), and Lut de Baere (responsible for the MetabERN Patients organizations management), have participated in the policy Round Table on Phenylketonuria (PKU) “‘Addressing the high burden and significant unmet needs in the management of PKU’” at the European Parliament on 11th July 2018 (see attached agenda).

The event, co-hosted by MEPs Nessa Childers and Deirdre Clune and organized in collaboration with ESPKU, was aimed to raise awareness of PKU, address ways to better manage the condition and improve patient outcomes.

In his talk on “The journey towards improving patient outcomes: What has been achieved?” Francjan highlighted the important role of MetabERN in providing a cross-sectorial environment in which inter-professional collaborative teams composed by health-care professionals and patient organizations cooperatively working together in a common collaborative effort aimed to address patient’s needs.

MetabERN facilitates cross border collaboration helping patients, families and carers find common fair, equitable and equal solutions across EU and reminding them they are not alone.

The Roundtable brought together different stakeholders with common interest in addressing unmet needs in the field of PKU, i.e. patients’ and health professionals’ organisations (psychologists, GP’s, nurses, neurologists, paediatricians, dieticians….), carers, social workers, payers and policy makers.

Phenylketonuria (PKU) is an inherited metabolic disorder that affects about one in every 10,000 children born in Europe. If left untreated, PKU results in increased phenylalanine concentrations in blood and brain. This can cause severe intellectual disability, epilepsy and behavioural problems. In Europe, the mean prevalence of the condition is approximately 1: 10,000 newborns.

PKU is increasingly recognised by policymakers as a condition which needs attention. However, continued efforts are required to keep the topic on the EU and national policy agendas, and this is what the Roundtable aims to achieve.

Search

  • News
  • Meetings & Conferences
  • EU Calls
  • Newsletter

Next events

No Events scheduled

more info

Latest news

  • ‘Un Amico Raro’ – An animated cartoon to explain the Anderson-Fabry disease
  • G2M: General Assembly of the French Network of Metabolic Rare Diseases
  • European Reference Networks: challenges and opportunities
  • ERN Research Mobility Fellowship | 15 March 2021
  • Generic Emergency Protocol: Feedback Needed

Archives

Metabern Newletter

logo

For more information please contact
Prof. Maurizio Scarpa, MD, PhD
MetabERN Coordinator

MetabERN is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Commission. For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern

Follow us on Twitter

Tweets by @Metab_ERN

MetabERN

  • Home
  • For Patients
    • What is an ERN?
    • Understand your Diagnosis
    • News for Patients
    • Meetings & Events
    • Support Groups
      • Find a Health Care Professional
      • Contact
    • Cross-border Healthcare
  • Our Network
  • ERN Expertise
    • Rare Diseases Subnetworks
    • Transversal Activities
    • Work Packages
    • Patient Board
  • Media
    • Informative Materials
  • What’s New
    • News
    • News for Patients
    • Meetings & Conferences
    • Newsletter
  • ERNs
  • Links
  • Contact
  • Privacy Policy

Copyright ©2017-2019 all rights reserved
Web by EFFIGE 2.0
To provide the best possible service, we use technical, statistical and third-party cookies on this site. Continuing the navigation you consent to use them. Accept Reject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT